Neurim Pharmaceuticals Ltd.
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.neurim.com
Clinical Trials
14
Trial Phases
4 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 225
- Registration Number
- NCT05267535
- Locations
- 🇺🇸
ATP Clinical Research, Costa Mesa, California, United States
🇺🇸Collaborative Neuroscience Research, LLC, Long Beach, California, United States
🇺🇸Asclepes Research Centers, P.C. Dba Alliance Research, Long Beach, California, United States
Efficacy and Safety of Slenyto for Insomnia in Children With ASD
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2021-03-12
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Registration Number
- NCT04233502
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
- First Posted Date
- 2015-11-25
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 371
- Registration Number
- NCT02615002
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Territory Neurology & Research Institute, Tucson, Arizona, United States
🇺🇸Citrials Inc, Bellflower, California, United States
Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
- First Posted Date
- 2013-07-24
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 125
- Registration Number
- NCT01906866
- Locations
- 🇺🇸
Southwest Autism Research and Resource Center (SARRC), Phoenix, Arizona, United States
🇺🇸Crystal BioMedical Research, LLC, Miami Lakes, Florida, United States
🇺🇸Lake Mary Pediatrics, Orange City, Florida, United States
Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances
- First Posted Date
- 2013-07-19
- Last Posted Date
- 2014-04-04
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT01903681
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, Netherlands
- Prev
- 1
- 2
- 3
- Next